f radiotherapy, in the United 
States and Europe. IBA is also a corporate member of the EANM, European Association of Nuclear Medicine, NAPT, an independent nonprofit 
organization to educate and increase awareness about the clinical benefits of proton therapy, iiA Global, an organization which aims to support the 
global irradiation industry and scientific community, the Alliance for Protontherapy, aiming to increase patient access to proton therapy for cancer 
patients by educating insurers, p